A retrospective genomic characterisation of the 2022 mpox outbreak in Belgium, and in vitro assessment of three antiviral compoundsResearch in context

A retrospective genomic characterisation of the 2022 mpox outbreak in Belgium, and in vitro assessment of three antiviral compoundsResearch in context

Summary: Background: Since the beginning of May 2022, cases of mpox have been reported in several European and American countries where the disease is nonendemic. We performed a retrospective genomic characterisation of the 2022 mpox outbreak in Belgium, and assessed the in vitro sensitivity of thr...

Full description

Saved in:
Bibliographic Details
Main Authors: Tony Wawina-Bokalanga, Bert Vanmechelen, Anne-Sophie Logist, Mandy Bloemen, Lies Laenen, Sébastien Bontems, Marie-Pierre Hayette, Cécile Meex, Christelle Meuris, Catherine Orban, Emmanuel André, Robert Snoeck, Guy Baele, Samuel L. Hong, Graciela Andrei, Piet Maes
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:EBioMedicine
Subjects:
Monkeypox virus
mpox
Whole-genome sequencing
Genomic analysis
Tecovirimat
Antivirals
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396424005243
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items